CORRESP Filing
Drugs Made In America Acquisition II Corp.
Date: Sept. 22, 2025 · CIK: 0002040475 · Accession: 0001213900-25-089929
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288791
Letter
September 22, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate & Construction
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ruairi Regan
Dorrie Yale
Babette Cooper
Isaac Esquivel
Re: Drugs Made In America Acquisition II Corp.
Registration Statement on Form S-1
Filed July 21, 2025, as amended
File No. 333-288791
Ladies and Gentlemen,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), the undersigned hereby joins in the request of Drugs Made In America Acquisition II Corp. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:30 p.m. Eastern Time on September 24, 2025, or as soon thereafter as practicable.
Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned wishes to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
* * *
[ Signature Page Follows ]
Very truly yours,
CANTOR FITZGERALD & CO.
Show Raw Text
CORRESP 1 filename1.htm September 22, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 Attention: Ruairi Regan Dorrie Yale Babette Cooper Isaac Esquivel Re: Drugs Made In America Acquisition II Corp. Registration Statement on Form S-1 Filed July 21, 2025, as amended File No. 333-288791 Ladies and Gentlemen, Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), the undersigned hereby joins in the request of Drugs Made In America Acquisition II Corp. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:30 p.m. Eastern Time on September 24, 2025, or as soon thereafter as practicable. Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned wishes to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. * * * [ Signature Page Follows ] Very truly yours, CANTOR FITZGERALD & CO. By: /s/ David Batalion Name: David Batalion Title: Managing Director, Investment Banking [ Signature Page to UW Acceleration Request ]